<DOC>
	<DOCNO>NCT03076021</DOCNO>
	<brief_summary>Specific Aim : To investigate isotretinoin ( 13-cis-retinoic acid ) administration decrease CYP2D6 activity adolescent patient .</brief_summary>
	<brief_title>Effects Isotretinoin CYP2D6 Activity</brief_title>
	<detailed_description>In aim , conduct drug-drug interaction study evaluate effect 13-cis-retinoic acid non-induced CYP2D6 activity adolescent patient . Secondary analysis evaluate relationship retinoid concentration CYP2D6 activity special population</detailed_description>
	<mesh_term>Isotretinoin</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Nonpregnant Adolescent ( 1221 year age ) Patients severe acne expect receive isotretinoin therapeutic reason Weight &lt; 80 lb Allergy adverse reaction dextromethorphan , vitamin A isotretinoin Pregnant planning become pregnant Unable follow isotretinoin risk evaluation mitigation strategy ( REMS ) program ( also know iPLEDGE program ) Chronic persistent cough accompany asthma , smoke COPD , Productive cough , Fever , Known kidney disease , Known liver disease , Diabetes Obesity , BMI â‰¥ 30 kg/m2 Bipolar disease , Attention deficit disorder , Social phobia , Concurrent use within 14 day drug know interact DM CYP2D6 drug know increase risk adverse effect DM Concurrent use product contain dextromethorphan Consuming food , beverage dietary supplement know interact DM CYP2D6 Unable give write informed consent/assent , Inability fast 4 hour prior study . Wards State</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>